深圳证券交易所宣布调整沪深港通合资格证券名单。自2026年4月28日起，唯 تک生物-B将被纳入该名单。 AI
排序理由 这是证券交易所合资格证券名单的例行调整，与人工智能无关。
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
深交所将生物技术公司纳入港股通
本文如何被排名
- Signal score
- 0 / 100
- Composite score across the factors below. Higher = stronger signal that this story matters right now.
- Newsworthiness bucket
- Meme
- 这是证券交易所合资格证券名单的例行调整，与人工智能无关。
- Source corroboration
- Single-source cluster
- Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
- Topics
- other
- Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
- AI-industry relevance
- Low
- Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
- Story freshness
- 163 days old
- Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.
完整方法见我们的编辑标准。
报道来源 [1]
-
深交所：沪深港通标的证券名单新增卓胜微电子-B
36氪获悉，深交所公告，港股通标的证券名单发生调整并自2026年4月28日起生效，调入迈威生物-B。